IL-6 levels decrease with SSRI treatment in patients with major depression
- PMID: 16158446
- DOI: 10.1002/hup.717
IL-6 levels decrease with SSRI treatment in patients with major depression
Abstract
Objective: Some evidence indicates that an immune response with an increased production of proinflammatory cytokines often accompanies major depression. The objective of this study was to examine the serum levels of IL-6 in patients with major depression and the changes occurring in IL-6 levels during treatment with selective serotonin reuptake inhibitors (SSRI).
Method: Twenty-three patients with a DSM-IV diagnosis of major depressive disorder and 23 healthy matched controls were included in the study. The severity of depression was measured with the Hamilton rating scale for depression. Blood samples for IL-6 levels were obtained at baseline and at week 6 of treatment and IL-6 concentrations were evaluated using a solid phase sandwich enzyme immunoassay. All patients were treated with an SSRI.
Results: The IL-6 levels showed no statistically significant difference between the patients and the controls at baseline. However, IL-6 levels after treatment with SSRIs were significantly lower compared with the baseline IL-6 levels of both the patients and the controls.
Conclusion: The results of this study suggest that proinflammatory cytokines show some changes during the course of treatment of major depression. These findings might also be considered as supporting the hypothesis of a modulatory role of antidepressants on the immune system.
Copyright (c) 2005 John Wiley & Sons, Ltd.
Similar articles
-
Plasma levels of interleukin-6 and selective serotonin reuptake inhibitor response in patients with major depressive disorder.Hum Psychopharmacol. 2013 Sep;28(5):466-70. doi: 10.1002/hup.2333. Epub 2013 Jun 30. Hum Psychopharmacol. 2013. PMID: 23813968
-
The Relationship Between Plasma Cytokine Levels and Response to Selective Serotonin Reuptake Inhibitor Treatment in Children and Adolescents with Depression and/or Anxiety Disorders.J Child Adolesc Psychopharmacol. 2016 Oct;26(8):727-732. doi: 10.1089/cap.2015.0147. Epub 2016 Jan 15. J Child Adolesc Psychopharmacol. 2016. PMID: 26771135
-
Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy.J Psychiatr Res. 2007 Apr-Jun;41(3-4):326-31. doi: 10.1016/j.jpsychires.2006.05.013. Epub 2006 Jul 25. J Psychiatr Res. 2007. PMID: 16870211 Clinical Trial.
-
Resolution of sleepiness and fatigue in major depressive disorder: A comparison of bupropion and the selective serotonin reuptake inhibitors.Biol Psychiatry. 2006 Dec 15;60(12):1350-5. doi: 10.1016/j.biopsych.2006.06.015. Epub 2006 Aug 24. Biol Psychiatry. 2006. PMID: 16934768 Review.
-
[Efficacy of atypical antipsychotics in depressive syndromes].Encephale. 2004 Nov-Dec;30(6):583-9. doi: 10.1016/s0013-7006(04)95474-7. Encephale. 2004. PMID: 15738862 Review. French.
Cited by
-
Critical Neurotransmitters in the Neuroimmune Network.Front Immunol. 2020 Aug 21;11:1869. doi: 10.3389/fimmu.2020.01869. eCollection 2020. Front Immunol. 2020. PMID: 32973771 Free PMC article. Review.
-
Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infection.Biomed Pharmacother. 2021 Jun;138:111437. doi: 10.1016/j.biopha.2021.111437. Epub 2021 Feb 25. Biomed Pharmacother. 2021. PMID: 33691249 Free PMC article.
-
Effects of antidepressant drug therapy with or without physical exercise on inflammatory biomarkers in major depressive disorder: a systematic review and meta-analysis of randomized controlled trials.Eur J Clin Pharmacol. 2022 Mar;78(3):339-349. doi: 10.1007/s00228-021-03240-8. Epub 2021 Oct 27. Eur J Clin Pharmacol. 2022. PMID: 34708271
-
Stress, depression, and coronary artery disease: modeling comorbidity in female primates.Neurosci Biobehav Rev. 2009 Feb;33(2):133-44. doi: 10.1016/j.neubiorev.2008.06.006. Epub 2008 Jun 24. Neurosci Biobehav Rev. 2009. PMID: 18619999 Free PMC article. Review.
-
Inflammation Models of Depression in Rodents: Relevance to Psychotropic Drug Discovery.Int J Neuropsychopharmacol. 2016 Sep 21;19(9):pyw028. doi: 10.1093/ijnp/pyw028. Print 2016 Sep. Int J Neuropsychopharmacol. 2016. PMID: 27026361 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources